Skip to main content

Table 2 Last Lipid Panel Results Prior to Any Microvascular Event or Censorship

From: The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus

Lipid Characteristics

All Patients

Event1

No Event2

P- Value3

N = 72,267

n = 7,271

n = 64,996

# Days from Last Lipid Panel to Any Microvascular Event/Censorship: mean ± SD

346.21

±351.43

148.40

±223.94

368.34

±356.15

<.0001

Lipid Panel Values: mean ± SD

LDL-C

109.08

±34.35

108.33

±36.47

109.16

±34.1

.0513

HDL-C

48.02

±14.13

46.72

±14.04

48.16

±14.13

<.0001

Triglycerides

163.35

±122

186.39

±186.41

160.77

±112.23

<.0001

Non-HDL-C

140.55

±40.25

143.19

±45.9

140.26

±39.56

<.0001

Lipid Goal Attainment Results: n, row%

LDL-C

30,395

42.06 %

3,185

43.80 %

27,210

41.86 %

.0015

HDL-C

37,946

52.51 %

3,527

48.51 %

34,419

52.96 %

<.0001

Triglycerides

43,577

60.30 %

3,948

54.30 %

39,629

60.97 %

<.0001

Non-HDL-C

30,737

42.53 %

3,032

41.70 %

27,705

42.63 %

.1299

  1. 1For those patients who experienced any corresponding microvascular event of interest (diabetic retinopathy/nephropathy/neuropathy), mean values of the last laboratory assessment prior to the first event are presented.
  2. 2For those patients who did not experience the microvascular event of interest (diabetic retinopathy/nephropathy/neuropathy), mean values of the last laboratory assessment prior to censorship (death, age >64 years, end of plan eligibility, or data period) are presented.
  3. 3P-value between the event and no event groups is significant at < .05.
  4. LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; TG: triglycerides.